© 2002 European Society of Cardiology
Prevalence of chronic heart failure in Southwestern Europe: the EPICA study
a Department of Internal Medicine, Medical Sciences School New University of Lisbon, Lisbon, Portugal
b Department of Cardiology, Medical Sciences School New University of Lisbon, Lisbon, Portugal
c EPICA Working Group Lisbon, Portugal
d Datamédica, Lisbon, Portugal
* Corresponding author. Av. Grão Vasco, 47-1°-Esq, 1500 Lisbon, Portugal. Tel.: +351-21-760-4573; fax: +351-21-301-7958
| Abstract |
|---|
Aim: To estimate the prevalence of chronic heart failure (CHF) in mainland Portugal in 1998.
Methods and population: A community-based epidemiological survey involving subjects attending primary care centres selected by a combined two-stage sampling and stratified procedure. General practitioners (GPs) randomly selected in proportion to the population of the District, evaluated subjects attending primary care centres aged over 25 years, recruited consecutively and stratified by age. CHF cases were identified according to the Guidelines of the European Society of Cardiology for CHF diagnosis.
Results: 5434 eligible subjects were evaluated by 365 GPs; 551 patients with CHF were identified. The overall prevalence and 95% CI of CHF in mainland Portugal is 4.36% (3.69–5.02%), 4.33% in males (3.19–5.46%), and 4.38% in females (3.64–5.13%). Age-specific CHF prevalence was as follows: 1.36% in the 25–49 years-old group (0.39–2.33%), 2.93% in the 50–59 years-old group (5.58–9.37%), 7.63% in the 60–69 years-old group (5.58–9.37%), 12.67% in the 70–79 years-old group (10.73–14.6%), and 16.14% in group over 80 years old (13.81–18.47%). The prevalence of CHF due to systolic dysfunction was 1.3% and the prevalence of CHF with normal systolic function was 1.7%.
Conclusions: The overall prevalence of CHF in Portugal was slightly higher than that of other European studies and increases sharply with age. The prevalence of CHF due to systolic dysfunction is very similar to that reported by other recent European studies. The differences found may correspond to differences in methodology rather than actual differences in the population.
Key Words: Heart failure Epidemiology Prevalence Echocardiography Left ventricular dysfunction
Received November 19, 2001; Revised February 10, 2002; Accepted March 18, 2002
1 Address: Serviço de Medicina, Hospital de S. Francisco Xavier, 1400 Lisbon, Portugal.
2 Address: Serviço de Cardiologia, Hospital de Pulido Valente, 1750 Lisbon, Portugal.
3 Address: Grupo de Investigação EPICA, Av. António Augusto de Aguiar 128, 1050 Lisbon, Portugal.
4 Address: R. Garcia de Orta, 70-2°, 1200-680 Lisbon, Portugal.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J-W Ha, D Choi, S Park, C-Y Shim, J-M Kim, S-H Moon, H-J Lee, E-Y Choi, and N Chung Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction Heart, March 15, 2009; 95(6): 490 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner CHAPTER 23 Heart Failure ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, J.-W. Ha, C. Y. Shim, E.-Y. Choi, J.-M. Kim, J.-A. Ahn, S.-W. Lee, S.-J. Rim, and N. Chung Gender-Related Difference in Arterial Elastance During Exercise in Patients With Hypertension Hypertension, April 1, 2008; 51(4): 1163 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Groban, L. M. Yamaleyeva, B. M. Westwood, T. T. Houle, M. Lin, D. W. Kitzman, and M. C. Chappell Progressive Diastolic Dysfunction in the Female mRen(2).Lewis Rat: Influence of Salt and Ovarian Hormones J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2008; 63(1): 3 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A.F. van Tol, R. J. Huijsmans, D. W. Kroon, M. Schothorst, and G. Kwakkel Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta-analysis Eur J Heart Fail, December 1, 2006; 8(8): 841 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm, and W. Herrmann A review of homocysteine and heart failure Eur J Heart Fail, October 1, 2006; 8(6): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Guerra, R. Roncon-Albuquerque Jr, A. P. Lourenco, I. Falcao-Pires, P. Cibrao-Coutinho, and A. F. Leite-Moreira Remote myocardium gene expression after 30 and 120 min of ischaemia in the rat Exp Physiol, March 1, 2006; 91(2): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. H. Cann Hypothesis: dietary iodine intake in the etiology of cardiovascular disease. J. Am. Coll. Nutr., February 1, 2006; 25(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Redfield, S. J. Jacobsen, B. A. Borlaug, R. J. Rodeheffer, and D. A. Kass Age- and Gender-Related Ventricular-Vascular Stiffening: A Community-Based Study Circulation, October 11, 2005; 112(15): 2254 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Bari, C. Pozzi, M. C. Cavallini, F. Innocenti, G. Baldereschi, W. De Alfieri, E. Antonini, R. Pini, G. Masotti, and N. Marchionni The diagnosis of heart failure in the community: Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1601 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G.F. Cleland, K. Goode, and K. Lalukota Diagnosing heart failure in primary care: lessons from EPICA Eur J Heart Fail, October 1, 2004; 6(6): 793 - 794. [Full Text] [PDF] |
||||
![]() |
C. Fonseca, H. Morais, T. Mota, F. Matias, C. Costa, A. Gouveia-Oliveira, F. Ceia, and on behalf of the EPICA Investigators The diagnosis of heart failure in primary care: value of symptoms and signs Eur J Heart Fail, October 1, 2004; 6(6): 795 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ceia, C. Fonseca, T. Mota, H. Morais, F. Matias, C. Costa, and A. G. Oliveira Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy Eur J Heart Fail, October 1, 2004; 6(6): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fonseca, T. Mota, H. Morais, F. Matias, C. Costa, A. G. Oliveira, F. Ceia, and on behalf of the EPICA Investigators The value of the electrocardiogram and chest X-ray for confirming or refuting a suspected diagnosis of heart failure in the community Eur J Heart Fail, October 1, 2004; 6(6): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fonseca, A. G. Oliveira, T. Mota, F. Matias, H. Morais, C. Costa, F. Ceia, and on behalf of the EPICA Investigators Evaluation of the performance and concordance of clinical questionnaires for the diagnosis of heart failure in primary care Eur J Heart Fail, October 1, 2004; 6(6): 813 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
N F Murphy, C R Simpson, F A McAlister, S Stewart, K MacIntyre, M Kirkpatrick, J Chalmers, A Redpath, S Capewell, and J J V McMurray National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland Heart, October 1, 2004; 90(10): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis J. Am. Coll. Cardiol., February 4, 2004; 43(3): 317 - 327. [Abstract] [Full Text] [PDF] |
||||








